HEADER PROTEASE/PROTEASE INHIBITOR 27-SEP-16 5TG1 TITLE 1.40 A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX WITH TITLE 2 THE A M-CHLOROPHENYL SUBSTITUTED MACROCYCLIC INHIBITOR (17-MER) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1101-1281; COMPND 5 EC: 3.4.22.66; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: RESIDUES MHHHHHH ARE FROM THE PURIFICATION TAG. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NORWALK VIRUS; SOURCE 3 ORGANISM_COMMON: HU/NV/NV/1968/US; SOURCE 4 ORGANISM_TAXID: 524364; SOURCE 5 STRAIN: GI/HUMAN/UNITED STATES/NORWALK/1968; SOURCE 6 GENE: ORF1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, NOROVIRUS, NORWALK VIRUS, ANTIVIRAL INHIBITORS, MACROCYCLIC KEYWDS 2 INHIBITOR, PROTEASE-PROTEASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,K.P.BATTAILE,N.MEHZABEEN,V.C.DAMALANKA,Y.KIM, AUTHOR 2 A.C.G.KANKANAMALAGE,K.-O.CHANG,W.C.GROUTAS REVDAT 4 04-OCT-23 5TG1 1 REMARK REVDAT 3 11-DEC-19 5TG1 1 REMARK REVDAT 2 27-SEP-17 5TG1 1 REMARK REVDAT 1 11-JAN-17 5TG1 0 JRNL AUTH V.C.DAMALANKA,Y.KIM,A.C.GALASITI KANKANAMALAGE, JRNL AUTH 2 G.H.LUSHINGTON,N.MEHZABEEN,K.P.BATTAILE,S.LOVELL,K.O.CHANG, JRNL AUTH 3 W.C.GROUTAS JRNL TITL DESIGN, SYNTHESIS, AND EVALUATION OF A NOVEL SERIES OF JRNL TITL 2 MACROCYCLIC INHIBITORS OF NOROVIRUS 3CL PROTEASE. JRNL REF EUR J MED CHEM V. 127 41 2016 JRNL REFN ISSN 1768-3254 JRNL PMID 28038326 JRNL DOI 10.1016/J.EJMECH.2016.12.033 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2075 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.070 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 25213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.143 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.690 REMARK 3 FREE R VALUE TEST SET COUNT : 1183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.8375 - 2.7994 0.97 3108 164 0.1479 0.1773 REMARK 3 2 2.7994 - 2.2222 0.97 3039 156 0.1505 0.2057 REMARK 3 3 2.2222 - 1.9413 0.98 3030 143 0.1230 0.1787 REMARK 3 4 1.9413 - 1.7638 0.97 3023 135 0.1231 0.1741 REMARK 3 5 1.7638 - 1.6374 0.97 3047 133 0.1297 0.2021 REMARK 3 6 1.6374 - 1.5409 0.95 2925 147 0.1361 0.2363 REMARK 3 7 1.5409 - 1.4637 0.95 2930 155 0.1573 0.2235 REMARK 3 8 1.4637 - 1.4000 0.94 2928 150 0.1929 0.2641 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.050 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 1323 REMARK 3 ANGLE : 1.035 1807 REMARK 3 CHIRALITY : 0.089 209 REMARK 3 PLANARITY : 0.007 227 REMARK 3 DIHEDRAL : 17.885 480 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC ATOMIC DISPLACEMENT REMARK 3 PARAMETERS WERE REFINED FOR ALL ATOMS EXCEPT SOLVENT MOLECULES. REMARK 4 REMARK 4 5TG1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000224182. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25218 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 31.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.69100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.7 REMARK 200 STARTING MODEL: 3UR9 REMARK 200 REMARK 200 REMARK: PRISM REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 25.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG 2000 MME, 150 POTASSIUM REMARK 280 BROMIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 32.19850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.24750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 32.19850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.24750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 411 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 421 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 ALA A 1 REMARK 465 PRO A 2 REMARK 465 PRO A 3 REMARK 465 THR A 123 REMARK 465 GLY A 124 REMARK 465 GLY A 164 REMARK 465 ALA A 173 REMARK 465 GLY A 174 REMARK 465 GLU A 175 REMARK 465 GLY A 176 REMARK 465 GLU A 177 REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 LEU A 180 REMARK 465 GLU A 181 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 11 CE NZ REMARK 470 GLU A 75 CD OE1 OE2 REMARK 470 GLU A 79 CD OE1 OE2 REMARK 470 ARG A 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 LYS A 146 CD CE NZ REMARK 470 LYS A 162 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 323 O HOH A 373 2.00 REMARK 500 O HOH A 340 O HOH A 365 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 310 O HOH A 407 49410 2.01 REMARK 500 O HOH A 376 O HOH A 393 3455 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: CYCLIC PEPTIDE INHIBITOR REMARK 630 MOLECULE NAME: (4S,7S,17S)-17-(3-CHLOROPHENYL)-7-(HYDROXYMETHYL)-4- REMARK 630 (2-METHYLPROPYL)-1-OXA-3,6,11-TRIAZACYCLOHEPTADECANE-2,5,10-TRIONE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 V56 A 203 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 7C0 LEU GAU REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V56 A 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TG2 RELATED DB: PDB DBREF 5TG1 A 1 181 UNP Q83883 POLG_NVN68 1101 1281 SEQADV 5TG1 MET A -6 UNP Q83883 INITIATING METHIONINE SEQADV 5TG1 HIS A -5 UNP Q83883 EXPRESSION TAG SEQADV 5TG1 HIS A -4 UNP Q83883 EXPRESSION TAG SEQADV 5TG1 HIS A -3 UNP Q83883 EXPRESSION TAG SEQADV 5TG1 HIS A -2 UNP Q83883 EXPRESSION TAG SEQADV 5TG1 HIS A -1 UNP Q83883 EXPRESSION TAG SEQADV 5TG1 HIS A 0 UNP Q83883 EXPRESSION TAG SEQRES 1 A 188 MET HIS HIS HIS HIS HIS HIS ALA PRO PRO THR LEU TRP SEQRES 2 A 188 SER ARG VAL THR LYS PHE GLY SER GLY TRP GLY PHE TRP SEQRES 3 A 188 VAL SER PRO THR VAL PHE ILE THR THR THR HIS VAL VAL SEQRES 4 A 188 PRO THR GLY VAL LYS GLU PHE PHE GLY GLU PRO LEU SER SEQRES 5 A 188 SER ILE ALA ILE HIS GLN ALA GLY GLU PHE THR GLN PHE SEQRES 6 A 188 ARG PHE SER LYS LYS MET ARG PRO ASP LEU THR GLY MET SEQRES 7 A 188 VAL LEU GLU GLU GLY CYS PRO GLU GLY THR VAL CYS SER SEQRES 8 A 188 VAL LEU ILE LYS ARG ASP SER GLY GLU LEU LEU PRO LEU SEQRES 9 A 188 ALA VAL ARG MET GLY ALA ILE ALA SER MET ARG ILE GLN SEQRES 10 A 188 GLY ARG LEU VAL HIS GLY GLN SER GLY MET LEU LEU THR SEQRES 11 A 188 GLY ALA ASN ALA LYS GLY MET ASP LEU GLY THR ILE PRO SEQRES 12 A 188 GLY ASP CYS GLY ALA PRO TYR VAL HIS LYS ARG GLY ASN SEQRES 13 A 188 ASP TRP VAL VAL CYS GLY VAL HIS ALA ALA ALA THR LYS SEQRES 14 A 188 SER GLY ASN THR VAL VAL CYS ALA VAL GLN ALA GLY GLU SEQRES 15 A 188 GLY GLU THR ALA LEU GLU HET CL A 201 1 HET CL A 202 1 HET V56 A 203 33 HETNAM CL CHLORIDE ION HETNAM V56 (4S,7S,17S)-17-(3-CHLOROPHENYL)-7-(HYDROXYMETHYL)-4-(2- HETNAM 2 V56 METHYLPROPYL)-1-OXA-3,6,11-TRIAZACYCLOHEPTADECANE-2,5, HETNAM 3 V56 10-TRIONE FORMUL 2 CL 2(CL 1-) FORMUL 4 V56 C24 H36 CL N3 O5 FORMUL 5 HOH *128(H2 O) HELIX 1 AA1 LEU A 5 SER A 7 5 3 HELIX 2 AA2 HIS A 30 VAL A 32 5 3 HELIX 3 AA3 ASN A 126 MET A 130 1 5 HELIX 4 AA4 ILE A 135 CYS A 139 5 5 SHEET 1 AA1 5 VAL A 9 PHE A 12 0 SHEET 2 AA1 5 GLY A 15 TRP A 19 -1 O GLY A 15 N PHE A 12 SHEET 3 AA1 5 VAL A 24 THR A 28 -1 O ILE A 26 N PHE A 18 SHEET 4 AA1 5 PHE A 55 PHE A 60 -1 O PHE A 58 N PHE A 25 SHEET 5 AA1 5 ILE A 47 ALA A 52 -1 N ALA A 48 O ARG A 59 SHEET 1 AA2 2 GLU A 38 PHE A 39 0 SHEET 2 AA2 2 GLU A 42 PRO A 43 -1 O GLU A 42 N PHE A 39 SHEET 1 AA3 8 VAL A 72 LEU A 73 0 SHEET 2 AA3 8 ASP A 150 ALA A 160 1 O VAL A 153 N VAL A 72 SHEET 3 AA3 8 THR A 166 ALA A 170 -1 O VAL A 168 N ALA A 159 SHEET 4 AA3 8 ARG A 112 LEU A 121 -1 N GLY A 119 O VAL A 167 SHEET 5 AA3 8 LEU A 94 ILE A 109 -1 N MET A 107 O VAL A 114 SHEET 6 AA3 8 VAL A 82 LYS A 88 -1 N ILE A 87 O LEU A 95 SHEET 7 AA3 8 PRO A 142 ARG A 147 -1 O VAL A 144 N SER A 84 SHEET 8 AA3 8 ASP A 150 ALA A 160 -1 O ASP A 150 N ARG A 147 LINK SG CYS A 139 C12 V56 A 203 1555 1555 1.81 SITE 1 AC1 4 ARG A 112 LEU A 113 HOH A 331 HOH A 355 SITE 1 AC2 3 THR A 4 LEU A 5 ARG A 8 SITE 1 AC3 14 HIS A 30 ILE A 109 GLN A 110 GLY A 133 SITE 2 AC3 14 THR A 134 ILE A 135 PRO A 136 CYS A 139 SITE 3 AC3 14 GLY A 148 ALA A 158 ALA A 159 ALA A 160 SITE 4 AC3 14 HOH A 337 HOH A 369 CRYST1 64.397 36.495 61.474 90.00 112.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015529 0.000000 0.006432 0.00000 SCALE2 0.000000 0.027401 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017607 0.00000